国投证券：首予先瑞达医疗-B(06669)“买入”评级全球领先的创新型医疗器械

26 11 月, 2025

One Min Read

7 Views

Last Update: 26 11 月, 2025

Written By

Other Articles

Previous

港股异动 | 中联重科(01157)涨近3% 大吨位起重机批量交付西芒杜矿区公司海外收入规模与质量双升

Next

大摩：同程旅行(00780)第三季业绩略胜预期目标价29港元维持“增持”评级

Related Posts

先消灭低价股！

1 Min Read

假期市场思考：A股还是美股？

1 Min Read

香港证券两日成交额破百亿！港股仍有市场？

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept